{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:53:56Z","timestamp":1790787236437,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,2,26]],"date-time":"2020-02-26T00:00:00Z","timestamp":1582675200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004829","name":"Department of Science and Technology of Sichuan Province","doi-asserted-by":"publisher","award":["2019YJ0048"],"award-info":[{"award-number":["2019YJ0048"]}],"id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004829","name":"Department of Science and Technology of Sichuan Province","doi-asserted-by":"publisher","award":["19YYJC2250"],"award-info":[{"award-number":["19YYJC2250"]}],"id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81603057"],"award-info":[{"award-number":["81603057"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013314","name":"Higher Education Discipline Innovation Project","doi-asserted-by":"publisher","award":["B18035"],"award-info":[{"award-number":["B18035"]}],"id":[{"id":"10.13039\/501100013314","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.apsb.2020.02.011","type":"journal-article","created":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T12:00:26Z","timestamp":1583323226000},"page":"1094-1105","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["The construction of in\u00a0vitro nasal cavity-mimic M-cell model, design of M cell-targeting nanoparticles and evaluation of mucosal vaccination by nasal administration"],"prefix":"10.1016","volume":"10","author":[{"given":"Xiaotong","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianchun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingfeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huile","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2020.02.011_bib1","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1023\/B:PHAR.0000026823.82950.ff","article-title":"Nasal route and drug delivery systems","volume":"26","author":"T\u00fcrker","year":"2004","journal-title":"Pharm World Sci"},{"key":"10.1016\/j.apsb.2020.02.011_bib2","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.jconrel.2017.09.001","article-title":"Progress in brain targeting drug delivery system by nasal route","volume":"268","author":"Khan","year":"2017","journal-title":"J Contr Release"},{"key":"10.1016\/j.apsb.2020.02.011_bib3","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.apsb.2016.05.013","article-title":"Progress and perspectives on targeting nanoparticles for brain drug delivery","volume":"6","author":"Gao","year":"2016","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2020.02.011_bib4","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.apsb.2019.08.003","article-title":"Recent progress in drug delivery","volume":"9","author":"Li","year":"2019","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2020.02.011_bib5","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/j.cclet.2018.10.037","article-title":"Nano-formulations for transdermal drug delivery: a review","volume":"29","author":"Zhou","year":"2018","journal-title":"Chin Chem Lett"},{"key":"10.1016\/j.apsb.2020.02.011_bib6","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.vetmic.2015.03.005","article-title":"Nasal immunization with M cell-targeting ligand-conjugated ApxIIA toxin fragment induces protective immunity against Actinobacillus pleuropneumoniae infection in a murine model","volume":"177","author":"Park","year":"2015","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.apsb.2020.02.011_bib7","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/nri3251","article-title":"Recent progress in mucosal vaccine development: potential and limitations","volume":"12","author":"Lycke","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.apsb.2020.02.011_bib8","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s12934-019-1151-8","article-title":"Intranasal administration with recombinant Bacillus subtilis induces strong mucosal immune responses against pseudorabies","volume":"18","author":"Wang","year":"2019","journal-title":"Microb Cell Factories"},{"key":"10.1016\/j.apsb.2020.02.011_bib9","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/nri1439","article-title":"NALT-versus PEYER'S-patch-mediated mucosal immunity","volume":"4","author":"Kiyono","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.apsb.2020.02.011_bib10","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ijpharm.2017.07.012","article-title":"Nasal nanovaccines","volume":"530","author":"Bernocchi","year":"2017","journal-title":"Int J Pharm"},{"key":"10.1016\/j.apsb.2020.02.011_bib11","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1007\/s11095-009-9845-y","article-title":"Physicochemical and immunological characterization of N,N,N-trimethyl chitosan-coated whole inactivated influenza virus vaccine for intranasal administration","volume":"26","author":"Hagenaars","year":"2009","journal-title":"Pharm Res (N Y)"},{"key":"10.1016\/j.apsb.2020.02.011_bib12","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1086\/521304","article-title":"Cross-protection against H5N1 influenza virus infection is afforded by intranasal inoculation with seasonal trivalent inactivated influenza vaccine","volume":"196","author":"Ichinohe","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.apsb.2020.02.011_bib13","doi-asserted-by":"crossref","first-page":"4354","DOI":"10.1016\/j.vaccine.2018.05.075","article-title":"Intranasal inoculate of influenza virus vaccine against lethal virus challenge","volume":"36","author":"Fan","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.apsb.2020.02.011_bib14","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.tiv.2004.07.003","article-title":"The use of human nasal in\u00a0vitro cell systems during drug discovery and development","volume":"19","author":"Dimova","year":"2005","journal-title":"Toxicol Vitro"},{"key":"10.1016\/j.apsb.2020.02.011_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2016.09.086","article-title":"Application of RPMI 2650 as a cell model to evaluate solid formulations for intranasal delivery of drugs","volume":"515","author":"Gon\u00e7alves","year":"2016","journal-title":"Int J Pharm"},{"key":"10.1016\/j.apsb.2020.02.011_bib16","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s11095-014-1494-0","article-title":"The characterization of the human nasal epithelial cell line RPMI 2650 under different culture conditions and their optimization for an appropriate in\u00a0vitro nasal model","volume":"32","author":"Kreft","year":"2015","journal-title":"Pharm Res (N Y)"},{"key":"10.1016\/j.apsb.2020.02.011_bib17","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1002\/jbm.b.34215","article-title":"Surface assembly of poly(I:C) on polyethyleneimine-modified gelatin nanoparticles as immunostimulatory carriers for mucosal antigen delivery","volume":"107","author":"Lin","year":"2019","journal-title":"J Biomed Mater Res B Appl Biomater"},{"key":"10.1016\/j.apsb.2020.02.011_bib18","doi-asserted-by":"crossref","first-page":"6711","DOI":"10.1016\/j.vaccine.2014.08.089","article-title":"The mucosal immune system for vaccine development","volume":"32","author":"Lamichhane","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.apsb.2020.02.011_bib19","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1007\/s004289900177","article-title":"Evidence of M cells as portals of entry for antigens in the nasopharyngeal lymphoid tissue of humans","volume":"436","author":"Fujimura","year":"2000","journal-title":"Virchows Arch"},{"key":"10.1016\/j.apsb.2020.02.011_bib20","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/mi.2013.30","article-title":"Microfold (M) cells: important immunosurveillance posts in the intestinal epithelium","volume":"6","author":"Mabbott","year":"2013","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.apsb.2020.02.011_bib21","doi-asserted-by":"crossref","first-page":"5277","DOI":"10.4049\/jimmunol.1102077","article-title":"Convergent and divergent development among M cell lineages in mouse mucosal epithelium","volume":"187","author":"Wang","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.apsb.2020.02.011_bib22","doi-asserted-by":"crossref","first-page":"5787","DOI":"10.4049\/jimmunol.0903184","article-title":"The M cell-targeting ligand promotes antigen delivery and induces antigen-specific immune responses in mucosal vaccination","volume":"185","author":"Kim","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.apsb.2020.02.011_bib23","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.ejps.2005.04.015","article-title":"Transport of nanoparticles across an in\u00a0vitro model of the human intestinal follicle associated epithelium","volume":"25","author":"Des Rieux","year":"2005","journal-title":"Eur J Pharmaceut Sci"},{"key":"10.1016\/j.apsb.2020.02.011_bib24","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejps.2017.05.054","article-title":"A new cell-to-cell interaction model for epithelial microfold cell formation and the enhancing effect of epidermal growth factor","volume":"106","author":"Chaikhumwang","year":"2017","journal-title":"Eur J Pharmaceut Sci"},{"key":"10.1016\/j.apsb.2020.02.011_bib25","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/j.cclet.2018.10.012","article-title":"The influence of nanoparticle shape on bilateral exocytosis from Caco-2 cells","volume":"29","author":"Zhuang","year":"2018","journal-title":"Chin Chem Lett"},{"key":"10.1016\/j.apsb.2020.02.011_bib26","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.ejps.2006.12.006","article-title":"An improved in\u00a0vitro model of human intestinal follicle-associated epithelium to study nanoparticle transport by M cells","volume":"30","author":"Des Rieux","year":"2007","journal-title":"Eur J Pharmaceut Sci"},{"key":"10.1016\/j.apsb.2020.02.011_bib27","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1038\/nprot.2017.041","article-title":"A human intestinal M-cell-like model for investigating particle, antigen and microorganism translocation","volume":"12","author":"Beloqui","year":"2017","journal-title":"Nat Protoc"},{"key":"10.1016\/j.apsb.2020.02.011_bib28","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1007\/s11095-006-0255-0","article-title":"Culture of Calu-3 cells at the air interface provides a representative model of the airway epithelial barrier","volume":"23","author":"Grainger","year":"2006","journal-title":"Pharm Res (N Y)"},{"key":"10.1016\/j.apsb.2020.02.011_bib29","article-title":"Comparative study of mucoadhesive and mucus-penetrative nanoparticles based on phospholipid complex to overcome the mucus barrier for inhaled delivery of baicalein","author":"Dong","year":"2019","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2020.02.011_bib30","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.tiv.2014.08.003","article-title":"Development of an in\u00a0vitro model of human bronchial epithelial barrier to study nanoparticle translocation","volume":"29","author":"George","year":"2015","journal-title":"Toxicol Vitro"},{"key":"10.1016\/j.apsb.2020.02.011_bib31","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ejpb.2010.12.030","article-title":"Calu-3 cells grown under AIC and LCC conditions: implications for dipeptide uptake and transepithelial transport of substances","volume":"78","author":"Stentebjerg-Andersen","year":"2011","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.apsb.2020.02.011_bib32","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1080\/10611860701637982","article-title":"M-cell targeted biodegradable PLGA nanoparticles for oral immunization against hepatitis B","volume":"15","author":"Gupta","year":"2007","journal-title":"J Drug Target"},{"key":"10.1016\/j.apsb.2020.02.011_bib33","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3109\/1061186X.2011.611516","article-title":"Microfold-cell targeted surface engineered polymeric nanoparticles for oral immunization","volume":"20","author":"Malik","year":"2012","journal-title":"J Drug Target"},{"key":"10.1016\/j.apsb.2020.02.011_bib34","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1006\/bbrc.2000.4038","article-title":"Expression of specific markers and particle transport in a new human intestinal M-cell model","volume":"279","author":"Gullberg","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.apsb.2020.02.011_bib35","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1124\/jpet.106.107847","article-title":"Identification of cell adhesion molecules in the human follicle-associated epithelium that improve nanoparticle uptake into the Peyer's patches","volume":"319","author":"Gullberg","year":"2006","journal-title":"J Pharmacol Exp Therapeut"},{"key":"10.1016\/j.apsb.2020.02.011_bib36","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ejpb.2009.04.009","article-title":"Targeting nanoparticles to M cells with non-peptidic ligands for oral vaccination","volume":"73","author":"Fievez","year":"2009","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.apsb.2020.02.011_bib37","doi-asserted-by":"crossref","first-page":"7738","DOI":"10.1016\/j.biomaterials.2010.06.059","article-title":"Targeted delivery of chitosan nanoparticles to Peyer's patch using M cell-homing peptide selected by phage display technique","volume":"31","author":"Yoo","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.apsb.2020.02.011_bib38","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1016\/j.vaccine.2004.11.052","article-title":"Mucosal targeting of allergen-loaded microspheres by Aleuria aurantia lectin","volume":"23","author":"Roth-Walter","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.apsb.2020.02.011_bib39","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jconrel.2007.04.021","article-title":"PEGylated PLGA-based nanoparticles targeting M cells for oral vaccination","volume":"120","author":"Garinot","year":"2007","journal-title":"J Contr Release"},{"key":"10.1016\/j.apsb.2020.02.011_bib40","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.apsb.2018.10.005","article-title":"Emerging transporter-targeted nanoparticulate drug delivery systems","volume":"9","author":"Su","year":"2019","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2020.02.011_bib41","doi-asserted-by":"crossref","first-page":"22571","DOI":"10.1021\/acsami.8b04847","article-title":"Coadministration of iRGD with multistage responsive nanoparticles enhanced tumor targeting and penetration abilities for breast cancer therapy","volume":"10","author":"Hu","year":"2018","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.apsb.2020.02.011_bib42","doi-asserted-by":"crossref","first-page":"27458","DOI":"10.1021\/acsami.5b09391","article-title":"A novel strategy through combining iRGD peptide with tumor-microenvironment-responsive and multistage nanoparticles for deep tumor penetration","volume":"7","author":"Cun","year":"2015","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.apsb.2020.02.011_bib43","doi-asserted-by":"crossref","first-page":"3724","DOI":"10.1128\/IAI.72.7.3724-3732.2004","article-title":"Mycobacterium avium subsp. paratuberculosis fibronectin attachment protein facilitates M-cell targeting and invasion through a fibronectin bridge with host integrins","volume":"72","author":"Secott","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.apsb.2020.02.011_bib44","doi-asserted-by":"crossref","first-page":"1901896","DOI":"10.1002\/adfm.201901896","article-title":"Tumor microenvironment-responsive dual drug dimer-loaded PEGylated bilirubin nanoparticles for improved drug delivery and enhanced immune-chemotherapy of breast cancer","volume":"29","author":"Yang","year":"2019","journal-title":"Adv Funct Mater"},{"key":"10.1016\/j.apsb.2020.02.011_bib45","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1021\/mp100255c","article-title":"Aerosolized PLA and PLGA nanoparticles enhance humoral, mucosal and cytokine responses to hepatitis B vaccine","volume":"8","author":"Thomas","year":"2011","journal-title":"Mol Pharm"},{"key":"10.1016\/j.apsb.2020.02.011_bib46","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.bbrc.2004.05.101","article-title":"Regulation of apical surface fluid and protein secretion in human airway epithelial cell line Calu-3","volume":"319","author":"Ramesh Babu","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.apsb.2020.02.011_bib47","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1365-2249.2004.02438.x","article-title":"Characterization of M cell formation and associated mononuclear cells during indomethacin-induced intestinal inflammation","volume":"136","author":"L\u00fcgering","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.apsb.2020.02.011_bib48","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0006-291X(02)02631-1","article-title":"Validation and quantitation of an in\u00a0vitro M-cell model","volume":"299","author":"Tyrer","year":"2002","journal-title":"Biophys Res Commun"},{"key":"10.1016\/j.apsb.2020.02.011_bib49","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/S1359-6446(05)03536-1","article-title":"Keynote review: intestinal Peyer's patch M cells and oral vaccine targeting","volume":"10","author":"Brayden","year":"2005","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.apsb.2020.02.011_bib50","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/rmv.398","article-title":"New generation of mucosal adjuvants for the induction of protective immunity","volume":"13","author":"Yuki","year":"2003","journal-title":"Rev Med Virol"}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383520300496?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383520300496?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T16:43:43Z","timestamp":1761929023000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211383520300496"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":50,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S2211383520300496"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2020.02.011","relation":{},"ISSN":["2211-3835"],"issn-type":[{"value":"2211-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The construction of in\u00a0vitro nasal cavity-mimic M-cell model, design of M cell-targeting nanoparticles and evaluation of mucosal vaccination by nasal administration","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2020.02.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}